Anti-cancer effects of Rhizoma Curcumae against doxorubicin-resistant breast cancer cells

被引:0
作者
Zhangfeng Zhong
Haibing Yu
Shengpeng Wang
Yitao Wang
Liao Cui
机构
[1] Guangdong Medical University,Guangdong Key Laboratory for Research and Development of Natural Drugs
[2] University of Macau,State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences
[3] Guangdong Medical University,School of Public Health
来源
Chinese Medicine | / 13卷
关键词
Rhizoma Curcumae; Multidrug resistance; Breast cancer; ABC transporters; Furanodiene;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 174 条
[1]  
Kumagai K(2014)Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers Br J Surg 101 321-338
[2]  
Rouvelas I(2012)Mortality, leukemic risk, and cardiovascular toxicity of adjuvant anthracycline and taxane chemotherapy in breast cancer: a meta-analysis Breast Cancer Res Treat 135 335-346
[3]  
Tsai JA(2013)Adjuvant treatment for gastric cancer: chemotherapy versus radiation Oncologist 18 1013-1021
[4]  
Mariosa D(2003)Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview Adv Drug Deliv Rev 55 3-29
[5]  
Klevebro F(2016)Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade Cancer Lett 370 153-164
[6]  
Lindblad M(2000)Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs Eur J Pharm Sci 11 265-283
[7]  
Petrelli F(2006)Emerging cancer therapeutic opportunities target DNA-repair systems Trends Pharmacol Sci 27 338-344
[8]  
Borgonovo K(2013)Targeting cellular metabolism to improve cancer therapeutics Cell Death Dis 4 e532-3710
[9]  
Cabiddu M(2017)The typical metabolic modifiers conferring improvement in cancer resistance Curr Med Chem 24 3698-692
[10]  
Lonati V(2012)Combinatorial drug therapy for cancer in the post-genomic era Nat Biotechnol 30 679-199